Matches in Nanopublications for { ?s ?p "[CHRNA3 (rs1051730) genotyping can improve customized chemotherapy based on tumor assessment of ERCC1 mRNA in stage IV NSCLC with PS 0.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP601646.RA6Y1mLhh_O7_ExWVois_4LMEg-QbHeB5PaWddfn2Erd0130_assertion description "[CHRNA3 (rs1051730) genotyping can improve customized chemotherapy based on tumor assessment of ERCC1 mRNA in stage IV NSCLC with PS 0.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP601646.RA6Y1mLhh_O7_ExWVois_4LMEg-QbHeB5PaWddfn2Erd0130_provenance.
- assertion description "[CHRNA3 (rs1051730) genotyping can improve customized chemotherapy based on tumor assessment of ERCC1 mRNA in stage IV NSCLC with PS 0.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[CHRNA3 (rs1051730) genotyping can improve customized chemotherapy based on tumor assessment of ERCC1 mRNA in stage IV NSCLC with PS 0.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP747924.RA8IlDow8ayAq4F-ntK0o6U61kZJo_wfLM5FOOtp8u0yo130_assertion description "[CHRNA3 (rs1051730) genotyping can improve customized chemotherapy based on tumor assessment of ERCC1 mRNA in stage IV NSCLC with PS 0.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP747924.RA8IlDow8ayAq4F-ntK0o6U61kZJo_wfLM5FOOtp8u0yo130_provenance.
- NP314124.RACkAPXsAI755zOQnUO6DcdV4PiSc6ja4teLa425S5oKM130_assertion description "[CHRNA3 (rs1051730) genotyping can improve customized chemotherapy based on tumor assessment of ERCC1 mRNA in stage IV NSCLC with PS 0.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP314124.RACkAPXsAI755zOQnUO6DcdV4PiSc6ja4teLa425S5oKM130_provenance.
- NP761535.RADHkoO7OdRqLD4UioZMm0P2jIYCrxgkRBEqwRld2ECNs130_assertion description "[CHRNA3 (rs1051730) genotyping can improve customized chemotherapy based on tumor assessment of ERCC1 mRNA in stage IV NSCLC with PS 0.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP761535.RADHkoO7OdRqLD4UioZMm0P2jIYCrxgkRBEqwRld2ECNs130_provenance.
- NP381497.RAgTZImHc0Zkx7X1fMVPprAdsFYiK0YnKTT2RYnXK4hX8130_assertion description "[CHRNA3 (rs1051730) genotyping can improve customized chemotherapy based on tumor assessment of ERCC1 mRNA in stage IV NSCLC with PS 0.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP381497.RAgTZImHc0Zkx7X1fMVPprAdsFYiK0YnKTT2RYnXK4hX8130_provenance.
- NP761540.RAyADhDoVKE4_31D54BTjRhWe9Rw0_xMdcqpnJlaEdc9Q130_assertion description "[CHRNA3 (rs1051730) genotyping can improve customized chemotherapy based on tumor assessment of ERCC1 mRNA in stage IV NSCLC with PS 0.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP761540.RAyADhDoVKE4_31D54BTjRhWe9Rw0_xMdcqpnJlaEdc9Q130_provenance.